BioNTech SE annual gross margin
2017
2018
2019
BioNTech SE Gross Margin Growth & History (BNTX)
BioNTech SE's gross margin was 84.00% for fiscal 2019.
View full BioNTech SE company overviewBioNTech SE annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | 84.00% | −5.27 pp |
| 2018 | 2018-12-31 | 89.27% | +4.40 pp |
| 2017 | 2017-12-31 | 84.87% | — |
BioNTech SE quarterly gross margin
No reported data
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|
BioNTech SE gross margin trends
Across the available reported history, BioNTech SE's gross margin decreased from 89.27% to 84.00%, a change of −5.27 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioNTech SE filings at SEC.gov ↗